e-learning
resources
Madrid 2019
Sunday, 29.09.2019
Innovations in idiopathic pulmonary fibrosis
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
The lower airways microbiome in patients with IPF and COPD
K. Knudsen (Bergen, Norway), R. Nielsen (Bergen, Norway), I. Haaland (Bergen, Norway), S. Lehmann (Bergen, Norway), T. Eagan (Bergen, Norway)
Source:
International Congress 2019 – Innovations in idiopathic pulmonary fibrosis
Session:
Innovations in idiopathic pulmonary fibrosis
Session type:
Thematic Poster
Number:
1326
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
K. Knudsen (Bergen, Norway), R. Nielsen (Bergen, Norway), I. Haaland (Bergen, Norway), S. Lehmann (Bergen, Norway), T. Eagan (Bergen, Norway). The lower airways microbiome in patients with IPF and COPD. 1326
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The impact of anti-IgE treatment on the airway microbiome in asthma.
Bronchoalveolar lavage (techniques, indications, results)
Altered microRNA profiles in the bronchoalveolar lavage fluid exosomes in asthma and COPD
Related content which might interest you:
The study of airway microbiome and mycobiome of COPD and AECOPD patients
Source: International Congress 2018 – Studies on the mechanisms underlying airway disease
Year: 2018
A study of the airway mycobiome in COPD patients and controls
Source: International Congress 2019 – Novel molecular pathways in lung cancer and COPD
Year: 2019
Is lung emphysema in COPD patients reflected by central airways inflammation?
Source: Eur Respir J 2003; 22: Suppl. 45, 207s
Year: 2003
The airway microbiota and exacerbations of COPD
Source: ERJ Open Res, 6 (3) 00168-2020; 10.1183/23120541.00168-2020
Year: 2020
The pulmonary microbiome and immunological activity in IPF patients.
Source: Virtual Congress 2020 – Translational aspects of idiopathic pulmonary fibrosis
Year: 2020
The microbiome in IPF
Source: International Congress 2014 – ERS/NEJM joint lunchtime session "The changing landscape of idiopathic pulmonary fibrosis (IPF)"
Year: 2014
The clinical importance of small airway involvement in patients with asthma and COPD
Source: International Congress 2019 – PG12 Recent advances in small airways diseases in patients with asthma and COPD
Year: 2019
The lung deposition of tiotropium in COPD patients is comparable to that in healthy subjects and independent of the stage of COPD disease
Source: Eur Respir J 2003; 22: Suppl. 45, 51s
Year: 2003
Pathology of small airways in non-COPD smokers with low diffusion capacity and patients with COPD
Source: Virtual Congress 2020 – Phenotypes of obstructive diseases
Year: 2020
Neutrophil elastase levels in sputum of patients with different airway diseases: COPD, bronchiectasis and asthma
Source: Eur Respir J 2002; 20: Suppl. 38, 95s
Year: 2002
The effect of exacerbations on the airway microbiota in children with non-CF bronchiectasis
Source: International Congress 2019 – A mixture of rare lung diseases
Year: 2019
Airway pathology in COPD compared to that in smokers with asthma
Source: Annual Congress 2008 - Smokers with asthma versus COPD: differences and similarities
Year: 2008
Upper and lower airway pathogens at exacerbation of COPD
Source: Eur Respir J 2005; 26: Suppl. 49, 250s
Year: 2005
Lung comparative function in COPD patients and in patients with chronic airflow obstruction due to tuberculosis lung disorder
Source: Eur Respir J 2006; 28: Suppl. 50, 130s
Year: 2006
Increased circulating alveolar epithelial microparticles in COPD patients
Source: International Congress 2015 – Modulating the immune system in COPD and asthma
Year: 2015
COPD and asthma overlap with bronchiectasis
Source: Eur Respir Monogr 2018; 81: 167-185
Year: 2018
The relationship between fibroblasts and airway structure in patients with asthma and chronic obstructive pulmonary disease (COPD)
Source: Eur Respir J 2001; 18: Suppl. 33, 148s
Year: 2001
Role of neutrophils in airway inflammation in patients with pneumoconiosis and COPD
Source: Eur Respir J 2004; 24: Suppl. 48, 322s
Year: 2004
Lung microbiome dynamics in COPD exacerbations
Source: Eur Respir J 2016; 47: 1082-1092
Year: 2016
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept